The Food and Drug Administration (FDA) has finally approved the weight loss drug Contrave.
The approval has been a long awaited outcome. When an FDA advisory panel voted to recommend the drug in December 2010, FDA approval was expected to follow. Instead, the FDA rejected the drug in February 2011, with a request for additional studies to determine whether or not the benefits of using the weight loss drug outweighed the cardiovascular side effects.
The study results were submitted in November 2013. The decision was finally announced this month granting approval. It is expected to be available sometime later in the fall of this year for patients with a prescription.